|
|
Blood, 15 November 2005, Vol. 106, No. 10, pp. 3524-3531.
Prepublished online as a Blood First Edition Paper on July 26, 2005; DOI 10.1182/blood-2005-03-1243.
Previous Article | Table of Contents | Next Article 
IMMUNOBIOLOGY
CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferondependent, TRAIL/DR5-mediated apoptosis
Jean-Philippe Herbeuval,
Jean-Charles Grivel,
Adriano Boasso,
Andrew W. Hardy,
Claire Chougnet,
Matthew J. Dolan,
Hideo Yagita,
Jeffrey D. Lifson, and
Gene M. Shearer
From the Experimental Immunology Branch, National Cancer Institute (NCI), National Institutes of Health (NIH), Bethesda, MD; Laboratory of Cellular and Molecular Biophysics, National Institute of Child Health and Human Development (NICHD), NIH, Bethesda, MD; Division of Molecular Immunology, Children's Hospital Research Foundation, Cincinnati, OH; Infectious Diseases Service, Wilford Hall Medical Center, Lackland AFB, TX; Department of Immunology, Juntendo University School of Medicine, Bunkyo-ku, Tokyo, Japan; and AIDS Vaccine Program, SAIC Frederick, Inc., NCI-Frederick, Frederick, MD.
It has been proposed that direct and indirect mechanisms contribute to the unresolved issue of CD4+ T-cell depletion that results from HIV-1 infection. We recently reported that plasma levels of tumor necrosis factor (TNF)related apoptosis-inducing ligand (TRAIL) are elevated in HIV-1infected patients and that they correlate with viral load. The present study investigates the expression of TRAIL death receptor 5 (DR5) in the peripheral-blood mononuclear cells (PBMCs) of HIV-1infected patients and its role in CD4+ T-cell death. DR5 expression was elevated and associated with the apoptotic marker annexin V. Apoptosis was reduced in CD4+ T cells when cultured with anti-DR5 antibody. CD4+, but not CD8+, T cells from uninfected donors expressed TRAIL, DR5, and activated caspase-3 when cultured with infectious or noninfectious HIV-1, resulting in preferential apoptosis of CD4+ T cells. TRAIL, caspase-3 expression, and apoptosis were type 1 interferon (IFN) dependent. Induction of apoptosis and DR5 expression required glycoprotein 120 (gp120)CD4 interaction. Finally, we analyzed DR5 expression by CD4+ T cells in highly active antiretroviral therapy (HAART)treated patients. The decreased viral loads and increased CD4 counts of HAART-responsive patients were associated with a decrease in DR5 mRNA expression by CD4+ T lymphocytes. We propose a novel model in which a type 1 IFNregulated TRAIL /DR5 mechanism induces apoptosis of HIV-1exposed CD4+ T cells.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. Stary, I. Klein, S. Kohlhofer, F. Koszik, T. Scherzer, L. Mullauer, H. Quendler, N. Kohrgruber, and G. Stingl
Plasmacytoid dendritic cells express TRAIL and induce CD4+ T-cell apoptosis in HIV-1 viremic patients
Blood,
October 29, 2009;
114(18):
3854 - 3863.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Meythaler, A. Martinot, Z. Wang, S. Pryputniewicz, M. Kasheta, B. Ling, P. A. Marx, S. O'Neil, and A. Kaur
Differential CD4+ T-Lymphocyte Apoptosis and Bystander T-Cell Activation in Rhesus Macaques and Sooty Mangabeys during Acute Simian Immunodeficiency Virus Infection
J. Virol.,
January 15, 2009;
83(2):
572 - 583.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Dabrowska, N. Kim, and A. Aldovini
Tat-Induced FOXO3a Is a Key Mediator of Apoptosis in HIV-1-Infected Human CD4+ T Lymphocytes
J. Immunol.,
December 15, 2008;
181(12):
8460 - 8477.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Haupt, N. Donhauser, C. Chaipan, P. Schuster, B. Puffer, R. S. Daniels, T. C. Greenough, F. Kirchhoff, and B. Schmidt
CD4 Binding Affinity Determines Human Immunodeficiency Virus Type 1-Induced Alpha Interferon Production in Plasmacytoid Dendritic Cells
J. Virol.,
September 1, 2008;
82(17):
8900 - 8905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Gasper-Smith, D. M. Crossman, J. F. Whitesides, N. Mensali, J. S. Ottinger, S. G. Plonk, M. A. Moody, G. Ferrari, K. J. Weinhold, S. E. Miller, et al.
Induction of Plasma (TRAIL), TNFR-2, Fas Ligand, and Plasma Microparticles after Human Immunodeficiency Virus Type 1 (HIV-1) Transmission: Implications for HIV-1 Vaccine Design
J. Virol.,
August 1, 2008;
82(15):
7700 - 7710.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Veazey, P. M. Acierno, K. J. McEvers, S. H. C. Baumeister, G. J. Foster, M. D. Rett, M. H. Newberg, M. J. Kuroda, K. Williams, E.-Y. Kim, et al.
Increased Loss of CCR5+ CD45RA- CD4+ T Cells in CD8+ Lymphocyte-Depleted Simian Immunodeficiency Virus-Infected Rhesus Monkeys
J. Virol.,
June 1, 2008;
82(11):
5618 - 5630.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Sedaghat, J. German, T. M. Teslovich, J. Cofrancesco Jr., C. C. Jie, C. C. Talbot Jr., and R. F. Siliciano
Chronic CD4+ T-Cell Activation and Depletion in Human Immunodeficiency Virus Type 1 Infection: Type I Interferon-Mediated Disruption of T-Cell Dynamics
J. Virol.,
February 15, 2008;
82(4):
1870 - 1883.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. W. Hardy, D. R. Graham, G. M. Shearer, and J.-P. Herbeuval
HIV turns plasmacytoid dendritic cells (pDC) into TRAIL-expressing killer pDC and down-regulates HIV coreceptors by Toll-like receptor 7-induced IFN-{alpha}
PNAS,
October 30, 2007;
104(44):
17453 - 17458.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. K. Sloan, J. P. Capitanio, R. P. Tarara, S. P. Mendoza, W. A. Mason, and S. W. Cole
Social Stress Enhances Sympathetic Innervation of Primate Lymph Nodes: Mechanisms and Implications for Viral Pathogenesis
J. Neurosci.,
August 15, 2007;
27(33):
8857 - 8865.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Kim, A. Dabrowska, R. G. Jenner, and A. Aldovini
Human and Simian Immunodeficiency Virus-Mediated Upregulation of the Apoptotic Factor TRAIL Occurs in Antigen-Presenting Cells from AIDS-Susceptible but Not from AIDS-Resistant Species
J. Virol.,
July 15, 2007;
81(14):
7584 - 7597.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. N. Brown, A. Trichel, and S. M. Barratt-Boyes
Parallel Loss of Myeloid and Plasmacytoid Dendritic Cells from Blood and Lymphoid Tissue in Simian AIDS
J. Immunol.,
June 1, 2007;
178(11):
6958 - 6967.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Boasso, J.-P. Herbeuval, A. W. Hardy, S. A. Anderson, M. J. Dolan, D. Fuchs, and G. M. Shearer
HIV inhibits CD4+ T-cell proliferation by inducing indoleamine 2,3-dioxygenase in plasmacytoid dendritic cells
Blood,
April 15, 2007;
109(8):
3351 - 3359.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dunn, M. Brunetto, G. Reynolds, T. Christophides, P. T. Kennedy, P. Lampertico, A. Das, A. R. Lopes, P. Borrow, K. Williams, et al.
Cytokines induced during chronic hepatitis B virus infection promote a pathway for NK cell-mediated liver damage
J. Exp. Med.,
March 19, 2007;
204(3):
667 - 680.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Rus, V. Nguyen, R. Puliaev, I. Puliaeva, V. Zernetkina, I. Luzina, J. C. Papadimitriou, and C. S. Via
T Cell TRAIL Promotes Murine Lupus by Sustaining Effector CD4 Th Cell Numbers and by Inhibiting CD8 CTL Activity
J. Immunol.,
March 15, 2007;
178(6):
3962 - 3972.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. S. Griffith, H. Kazama, R. L. VanOosten, J. K. Earle Jr., J. M. Herndon, D. R. Green, and T. A. Ferguson
Apoptotic Cells Induce Tolerance by Generating Helpless CD8+ T Cells That Produce TRAIL
J. Immunol.,
March 1, 2007;
178(5):
2679 - 2687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Viollet, V. Monceaux, F. Petit, R. H. T. Fang, M.-C. Cumont, B. Hurtrel, and J. Estaquier
Death of CD4+ T Cells from Lymph Nodes during Primary SIVmac251 Infection Predicts the Rate of AIDS Progression
J. Immunol.,
November 15, 2006;
177(10):
6685 - 6694.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Audige, M. Urosevic, E. Schlaepfer, R. Walker, D. Powell, S. Hallenberger, H. Joller, H.-U. Simon, R. Dummer, and R. F. Speck
Anti-HIV State but Not Apoptosis Depends on IFN Signature in CD4+ T Cells
J. Immunol.,
November 1, 2006;
177(9):
6227 - 6237.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Finzi, S. F. Plaeger, and C. W. Dieffenbach
Defective Virus Drives Human Immunodeficiency Virus Infection, Persistence, and Pathogenesis.
Clin. Vaccine Immunol.,
July 1, 2006;
13(7):
715 - 721.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-P. Herbeuval, J. Nilsson, A. Boasso, A. W. Hardy, M. J. Kruhlak, S. A. Anderson, M. J. Dolan, M. Dy, J. Andersson, and G. M. Shearer
Differential expression of IFN-{alpha} and TRAIL/DR5 in lymphoid tissue of progressor versus nonprogressor HIV-1-infected patients
PNAS,
May 2, 2006;
103(18):
7000 - 7005.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|